Um unsere Webseite für Sie optimal zu gestalten und fortlaufend verbessern zu können, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu.

Weitere Informationen zu Cookies erhalten Sie in unserer Datenschutzerklärung.

3D Cell Culture 2016: How close to 'in vivo' can we get? Models, applications & translation

Lecture Programme

Tuesday, 19 April 2016
Wednesday, 20 April, 2016
Thursday, 21 April 2016

Tuesday, 19 April 2016

10:00

Registration

11:00 Welcome Address
 
Imaging organotypic model systems

Chair: U. Marx, Technical University of Berlin/D

11:05 Keynote Lecture

Three dimensional imaging in living human lung tissue

S. Hippenstiel, Charité - Universitätsmedizin Berlin/D

11:50

Development of a 3D Human organotypic lung tumor model with 18F-FDG PET as a non-destructive read-out

D. Fecher¹; T. Schwarz²; S. Nietzer¹; G. Dandekar²; H. Walles¹; K. Lückerath³;
M. Steinke²

¹ University Hospital Würzburg, Translational Center Würzburg and Fraunhofer IGB, Würzburg/D; ² Translational Center Würzburg, Fraunhofer IGB and University Hospital Würzburg/D; ³ University Hospital Würzburg/D

12:10 3D culture models of vasculogenesis and sprouting angiogenesis for automated analysis in multiwell plates
l. Muller¹
¹ CIRB - INSERM, Paris/F
12:30 Lunch / Poster / Exhibition
 
Advanced bioprinting for complex tissue models

Chair: U. Graf-Hausner, Zurich University of Applied Science, Wädenswil/CH

14:00

Keynote Lecture

High resolution bioprinting to deal with tissue complexity

F. Guillemot, Poietis, Pessac/F

14:45

Bioprinted tissues for substance testing

M. Rimann¹; S. Laternser¹; E. Bono¹; M. Nosswitz¹; H. Keller²; O. Leupin²;
C. Wagner³; U. Graf-Hausner¹

¹ Zurich University of Applied Sciences, Waedenswil/CH; ² Novartis Institutes of Biomedical Research, Basel/CH; ³ University of Zurich/CH

15:05

Universal lab-on-a-chip platform for complex, perfused 3D tissues generated by 3D printing

F. Sonntag¹; J. Ströbel¹; S. Grünzner¹; M. Busek¹; U. Klotzbach¹; F. Schmieder¹

¹ Fraunhofer Institute of Material and Beam Technology IWS, Dresden/D

15:25

Immediate drop on demand technology – generating 3D-Cell Culture Models

L. Schober¹; C. Laske¹; I. Schuster²; T. Brode¹; A. Traube¹; A. Traube¹

¹ Fraunhofer IPA, Stuttgart/D; ² University of Stuttgart/D

15:45

Coffee Break

 
Strategies for high-throughput screening and analysis

Chair: J. Kelm, InSphero AG, Schlieren/CH

16:15

Phenotypic screening of autophagy modulating drugs in a three dimensional human brain cancer model by light sheet-based fluorescence microscopy: A new perspective in drug discovery

N. Ansari¹; F. Pampaloni¹; K. Kabat vel Job¹; E. H.K. Stelzer¹

¹ Goethe University Frankfurt/D

16:35

High throughput screenings of live cells in 2D and 3D environments based on superhydrophilic-superhydrophobic surface patterning

P. Levkin¹; A. Popova²; I. Neto²; K. Demir²

¹ Karlsruhe Institute of Technology (KIT), Eggenstein-Leopoldshafen/D; ² Karlsruhe Institute of Technology (KIT), Karlsruhe/D

16:55

High-throughput microfluidic platform for culture of 3D kidney tissue models

H. Lanz¹; M. Vormann¹; A. van den Heuvel¹; K. Wilschut¹; C. Ping¹; R. van Vught¹;
S. Trietsch¹; J. Joore¹; P. Vulto¹

¹ Mimetas, Leiden/NL

17:15

Keynote Lecture

Comprehensive molecular profiling of organoids and patient tissue in the context of toxicogenomics

R. Schlapbach, ETH Zurich/CH

18:00 End of Lecture Programme of Day 1
18:15
-
19:15
Section Member Assembly

DECHEMA Sections " Cell Culture Technology" and "Medical Biotechnology"

18:00
-

21:00

Poster Session / Poster Party

Wednesday, 20 April 2016

 
Understanding cancer development and progression

Chair: C. Burger, Merck KGaA, Darmstadt/D

09:00 Keynote Lecture

Modelling Wnt signalling in 3D culture

T. Dale, Cardiff University/UK

09:45

A novel culture strategy to model tumour microenvironment dynamics and study tumour-stroma interactions and disease progression

M. Estrada¹; S. Rebelo¹; V. Santo¹; S. Abreu¹; E. Davies²; M. Pinto³; H. Pereira⁴;
M. Smalley2; S. Barry5; E. Gualda⁴; P. Alves¹; E. Anderson6; C. Brito¹

¹ iBET/ITQBAX-UNL, Oeiras/P; ² Bioscience, Oncology iMed, AstraZeneca, Chesire/UK; ³ Institute of Molecular Pathology and Immunology, Porto/P; ⁴ Instituto Gulbenkian de Ciência, Oeiras/P; 5 European Cancer Stem Cell Institute, Cardiff/UK; 6 Boehringer Ingelheim, Vienna/A

10:05 Establishment of a standardized 3D in vitro tumor-stroma model

M. Mueller¹; S. Hensler¹; B. Kotkamp¹; K. Pohl²; N. Linde³; D. Stoll⁴

¹ Hochschule Furtwangen, Villingen-Schwenningen/D; ² NMI Reutlingen/D; ³ Mount Sinai School of Medicine, New York/USA; ⁴ Hochschule Albstadt-Sigmaringen/D

10:25 Coffee Break
 
Advanced models for substance testing: cancer therapy

Chair: T. Noll, University of Bielefeld/D

11:00 The Spheroid microtumor model is predictive for the therapeutic response in neoadjuvant breast cancer (SpheroNEO study)

K. Halfter¹; N. Ditsch²; B. Mayer³

¹ SpheroTec GmbH, Munich/D; ² Frauenklinik, Klinikum Großhadern, Munich/D;
³ Klinikum Großhadern, Munich/D

11:20 Multi-parametric 3D tumor microtissue-based phenotypic compound classification

J. Kelm¹; Z. Weydert¹; M. Lal²; L. Mathews Griner²; C. Schmees³; B. Gierke³;
M. Pawlak³; H. Cordes⁴; C. Thiel⁴; M. Ferrer²

¹ Insphero AG, Schlieren/CH; ² NCATS/NIH, Rockville/USA; ³ NMI Technologietransfer GmbH, Reutlingen/D; ⁴ RWTH Aachen University/D

11:40

Conditionally immortalized human endothelial cells for the investigation of KSHV latency and intervention in novel in vitro and in vivo models

T. Dubich¹; C. Lipps¹; M. Butueva¹; T. May²; D. Wirth¹

¹ Helmholtz Centre for Infection Research, Braunschweig/D; ² InSCREENeX GmbH, Braunschweig/D

12:00

Lunch / Poster / Exhibition

 
From the potential of organoids to multi-organ platforms

Chair: T. May, InSCREENeX GmbH, Braunschweig/D

14:00

Keynote Lecture

Organoids: An in vitro culture for all patients

R. Vries, foundation Hubrecht Organoid Technology, Utrecht/NL

14:45

Emulating the human vasculature in a multi-organ-chip platform

T. Hasenberg¹; K. Schimek²; S. Mühleder³; A. Dotzler¹; S. Bauer²; K. Labuda3;
W. Holnthoner3; H. Redl3; R. Lauster²; U. Marx¹

¹ TissUse GmbH, Berlin/D; ² Technische Universität Berlin/D; ³ Austrian Cluster for Tissue Regeneration, Vienna/A

15:05

Adding metabolic competence to 3D spheroid-based assays by using a microfluidic multi-tissue culturing platform

O. Frey¹; J. Kim¹; A. Hierlemann¹; D. Fluri²; J. Kelm²; T. Petreus³; E. Tang³;
R. Marchan⁴; J. Hengstler⁴

¹ ETH Zürich, Basel/CH; ² InSphero, Schlieren/CH; ³ AstraZeneca, Cheshire/UK;
⁴ IfaDo, Dortmund/D

15:25

Coffee Break

 
Assays and devices

Chair: M. Rimann, Zurich University of Applied Science,

Wädenswil/CH

16:00

Immortalized lung epithelial cells with in vivo like characteristics

T. May¹; T. Herfurth¹; R. Schucht¹

¹ InSCREENeX GmbH, Braunschweig/D

16:20

Designing assays and appropriate controls to interrogate 3D culture models

T. Riss¹

¹ Promega Corporation, Madison/USA

16:40

The Nunclon Sphera surface supports formation of three dimensional cancer spheroids in suspension

P. Reuter¹; C. Neeley²; L. Gaarn²

¹ Thermo Fisher Scientific, Langenselbold/D; ² Thermo Fisher Scientific, Rochester/USA

 
Advanced model systems: brain

Chair: M. Rimann, Zurich University of Applied Science,

Wädenswil/CH

17:00

Keynote Lecture

Modelling human neuronal maturation in 3D

I. Galimberti, Novartis Pharma AG, Basel/CH

17:45 End of lecture programme of Day 2
19:00 Conference Dinner, Historisches Kaufhaus

Thursday, 21 April 2016

 
Advanced model systems: from heart to brain

Chair: H. Hauser, Helmholtz Centre for Infection Research, Braunschweig/D

09:00 Keynote Lecture

Engineered human myocardium for drug screening applications

W.-H. Zimmermann, University Medical Center Göttingen/D

09:45

Intestinal organoids for functional studies on nutrient transport, sensing and incretin hormone secretion

T. Zietek¹; E. Rath¹; D. Haller¹; H. Daniel¹

¹ Technische Universität München, Freising/D

10:05

A 3D human co-culture microtissue model for nanoparticle effect and uptake studies at the placental barrier

C. Muoth¹; L. Diener¹; W. Jochum²; P. Wick¹; T. Buerki-Thurnherr¹

¹ Empa, St. Gallen/CH; ² Cantonal Hospital, St. Gallen/CH

10:25

Differentiation of human pluripotent stem cells into definitive endoderm cells in a flexible three-dimensional cell culturing matrix

R. Harjumäki¹; A. Taalas¹; L. Kanninen¹; J. Niklander¹; M. Yliperttula¹; Y. Lou¹

¹ University of Helsinki, Helsinki/FIN

10:45

Human pluripotent stem cell-based in vitro neural tissues and disease models for the chemical and pharmaceutical industry

M. Baquie¹; E. Eggermann²; A. Roux²; G. Fischler²; Z. Nayernia³; E. Cosset³;
K. Krause³; L. Stoppini²

¹ NEURIX, Plan-les-Ouates/CH; ² HEPIA University of Applied Sciences, Geneva/CH; ³ University and Hospitals of Geneva/CH

11:05

Coffee Break

 
Advanced model systems: skin in vitro

Chair: H. Hauser, Helmholtz Centre for Infection Research, Braunschweig/D

11:35 Keynote Lecture

Cosmetic substance testing – from static single skin cultures towards dynamic co-culture with human immunity or liver equivalents

J. Kühnl, Beiersdorf AG, Hamburg/D

12:10

Functionalized electrospun nanofibers for the development of a three-dimensional skin model

A. Rossi¹; J. Groll1; H. Walles2

¹ University Hospital Würzburg/D;2 University Hospital Würzburg and Fraunhofer IGB, Würzburg/D

12:30 Impedance Spectroscopy: A new tool to characterize reconstructed human epidermis

F. Groeber¹, L. Engelhardt2; H. Walles3; J. Hansmann3

¹ Fraunhofer IGB, Würzburg/D; 2 University of Würzburg/D; 3 University of Würzburg and Fraunhofer IGB, Würzburg/D

12:50 Lunch / Poster / Exhibition
 
Advanced model systems: osteoarthritis and bone repair

Chair: R. Pörtner, Hamburg University of Technology/D

13:50

Porcine chondrocyte micromasses – a model for osteoarthritis?

T. Dehne¹; N. Schlichting¹; K. Mans¹; M. Endres²; B. Stuhlmüller¹; C. Kaps²;
M. Sittinger¹; J. Ringe¹

¹ Charite Universitätsmedizin Berlin/D; ² TransTissue Technologies, Berlin/D

14:10

Evaluation of structure parameters for development of patient-matched 3D porous titanium bone implants

L. Zumofen1; K. Kopanska2; A. Kirchheim1; E. de Haller3; U. Graf-Hausner2

1 Zurich University of Applied Sciences, Winterthur/CH; 2 Zurich University of Applied Sciences, Wädenswil/CH; 3 -, -

14:30

Chondrogenic microtissues in the lab & for the clinic

M. Lehmann¹; F. Voss¹; F. Martin¹; P. Schläger¹; U. Anderer¹

¹ Brandenburgische Technische Universität Cottbus-Senftenberg, Senftenberg/D

14:50

Closing remarks

15:00 End of the conference

 

 

 

 

 

 

 

Jetzt Mitglied werden